CVRx, Inc. (CVRX)
NASDAQ: CVRX · IEX Real-Time Price · USD
10.12
-5.39 (-34.75%)
At close: May 1, 2024, 4:00 PM
9.96
-0.16 (-1.58%)
After-hours: May 1, 2024, 7:56 PM EDT
CVRx, Inc. Revenue
In the year 2023, CVRx, Inc. had annual revenue of $39.30M with 74.89% growth. Revenue in the quarter ending December 31, 2023 was $11.31M with 57.54% year-over-year growth.
Revenue (ttm)
$39.30M
Revenue Growth
+74.89%
P/S Ratio
5.56
Revenue / Employee
$196,475
Employees
200
Market Cap
218.55M USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 39.30M | 16.83M | 74.89% |
| Dec 31, 2022 | 22.47M | 9.43M | 72.36% |
| Dec 31, 2021 | 13.04M | 6.98M | 115.36% |
| Dec 31, 2020 | 6.05M | -204.00K | -3.26% |
| Dec 31, 2019 | 6.26M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Clover Health Investments | 2.03B |
| Organogenesis Holdings | 433.14M |
| SOPHiA GENETICS | 62.37M |
| Immutep | 4.58M |
| Atai Life Sciences | 314.00K |
| Fractyl Health | 120.00K |
CVRX News
- 1 day ago - CVRx Reports First Quarter 2024 Financial and Operating Results - GlobeNewsWire
- 15 days ago - CVRx to Report First Quarter 2024 Financial and Operating Results and Host Conference Call on April 30th, 2024 - GlobeNewsWire
- 16 days ago - CVRx announces availability of additional data supporting long-term benefits of Barostim - GlobeNewsWire
- 3 months ago - CVRx Announces Appointment of Kevin Hykes as President and Chief Executive Officer - GlobeNewsWire
- 3 months ago - CVRx Reports Fourth Quarter and Full Year 2023 Financial and Operating Results - GlobeNewsWire
- 3 months ago - CVRx to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call on January 25th, 2024 - GlobeNewsWire
- 4 months ago - CVRx to Present at the 42nd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 months ago - CVRx receives FDA approval for expanded labeling of Barostim - GlobeNewsWire